US Patent Litigations are now available. Check here

IP Verse

Multivalent Pcv2 Immunogenic Compositions And Methods Of Producing Them

PatentPatent Analysis

EP2275132

BOEHRINGER INGELHEIM ANIMAL HEALTH USA
Application Number
EP10174464A
Filing Date
Dec 28, 2006
Status
Granted And Under Opposition
Jan 29, 2021
Grant Date
Mar 3, 2021
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3035958B1
EP3554536B1
EP2785374B2

Biblio Summary

The patent EP2275132B1 was granted on Mar 3, 2021 by Boehringer Ingelheim Animal Health USA The patent is currently Granted And Under Opposition.

Patents Cited during Opposition New

Patent citations in opposition refer to prior patents or publications that may challenge the validity of a contested patent. These references help assess whether the invention is truly novel or overlaps with existing intellectual property.

Citation PhasePatent NumberPatent LinkCited Text
OppositionEP1968630B1
 N/A
OppositionWO2006072065
 N/A
OppositionUS2003170270
 N/A
OppositionUS6703023
 N/A
OppositionWO2005009462
 N/A
OppositionEP1926496
 N/A
OppositionWO0001409
 N/A
OppositionUS4745051
 N/A
OppositionUS2002146432
 N/A
OppositionWO9307898
 N/A
OppositionWO9418311
 N/A
OppositionGB2282811
 N/A
OppositionUS7122192
 N/A
OppositionUS6391314
 N/A
OppositionWO2005011731
 N/A
OppositionWO2006099561
 N/A
OppositionCA2784260
 N/A
OppositionEP0784685
 N/A
OppositionWO0116330
 N/A
OppositionEP1094070
 N/A
OppositionEP2473189
 N/A
OppositionEP1474067
 N/A
OppositionWO2018115435
 N/A

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents